HOME >> MEDICINE >> NEWS
UK Teenage Cancer Trust demands government action to aid young cancer patients

ersonal health than that of younger children; there is no clear pathway for referral and those referred to paediatric or adult centres are subject to different treatment protocols..

  • Relatively few young adults are enlisted in clinical trials compared to 75% of children; the pharmaceutical industry dominates this field and this age group in each country is proportionately too small to justify their involvement; some of the cancers are rare and do not inspire trials; hospital policies may exclude this group as too young or too old because of the way cancer provision is divided into paediatric or adult oncology; clinicians may see young people as non-compliant..

  • The variety of cancers in this age group includes both childhood and adult cancers the way the system is divided into generic childhood cancers and site specific adult cancers does not fit this in-between group..

  • This age group has emotional and social needs that are different in many ways from those of adults or children family issues are more complex in the transition from childhood to adulthood; the effect on fertility is a major and poignant consideration; relationships are crucial to teenagers and cancer isolates the young patient; education is vital for 16-18 year-olds yet is rarely provided in a hospital setting for this age group; being thrown from growing independence back into dependence upsets the family equilibrium; palliative care requires special expertise; there are long term effects on careers, the ability to get mortgages, insurance etc


    '"/>



    • Contact: Margaret Willson
    m.willson@mwcommunications.org.uk
    44-153-677-2181
    Teenage Cancer Trust
    1-Mar-2004


    Page: 1 2 3 4

    Related medicine news :

    1. Teenage highs and lows
    2. Teenage hormone therapy to reduce adult height of tall girls linked to reduced fertility
    3. Teenage smoking still worryingly high: Girls twice as likely as boys to puff away
    4. Teenagers with cancer are missing out on vital services
    5. Teenage girls lacking in vitamin D
    6. Teenage boys exposed to environmental pollutants
    7. Teenagers, drinking and driving: a quick trip to the grave
    8. Exercise Is The Best Means Of Weight Control In Teenagers
    9. Higher Prices Wont Stop Teenage Smokers
    10. Studies Find Public Policies For Children And Teenagers Not Very Effective
    11. Combination Of Interventions Are Found To Be Most Effective In Improving Driving Behavior Among Teenagers

    Post Your Comments:
    (Date:6/19/2013)... 19, 2013 Amber Roberson with ... Benefits, LLC, Native Care Health, LLC and Medcase, ... Health Underwriters’ (NAHU) new professional development course on ... This continuing education course for agents has been ... receive eleven education credits from the Missouri Department ...
    (Date:6/19/2013)... The Journal of Parasitology – Although ... software, it creates questions of ethics. For scientific publications, ... already published case shows, scientific publications need clear guidelines ... Journal of Parasitology features a commentary on ... article published in the Journal of the New York ...
    (Date:6/19/2013)... study published in the June 19 online edition of ... by researchers from the University of California, San Diego ... that take place when cardiac regeneration occurs in zebrafish ... that various cell lines in the heart are more ... than previously thought. , More importantly, the research reveals ...
    (Date:6/19/2013)... reveals significant disparities between minority and white clients ... programs. Moreover, these disparities vary widely from state ... for most states there,s something amiss," says Stephan ... "There are strong racial and ethnic disparities for ... treatment programs successfully, and those disparities are something ...
    (Date:6/19/2013)... -- Nearly 70 percent of Americans are ... than half take two, Mayo Clinic researchers say. ... prescribed, their study found. Twenty percent of patients ... to the findings, published online in the journal ... For audio and video of Dr. Jennifer St. ...
    Breaking Medicine News(10 mins):Health News:RWI Benefits, LLC Becomes PPACA Certified 2Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Fate of the heart: Researchers track cellular events leading to cardiac regeneration 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2
    (Date:6/19/2013)... MUMBAI, India , June 19, ... Book Bureau has recently added DrugPatentWatch ... Databases. ( http://www.bharatbook.com/drugpatentwatch-tour.pdf ) ... DrugPatentWatch provides comprehensive information on pharmaceutical, ... value-added information supports the critical business ...
    (Date:6/19/2013)... --  Nektar Therapeutics (Nasdaq: NKTR ) today ... study for NKTR-181, a first-in-class, opioid analgesic molecule ... slow rate of entry is designed to reduce the euphoria ... current opioid analgesics. 1 In the study data being ... in "drug liking" and "feeling high" scores and had highly ...
    (Date:6/19/2013)... June 19, 2013 BD Biosciences, a segment of ... a leading global medical technology company, today announced the launch ... latest in its line of high-performance research flow cytometers. ... multicolor analysis with the most compact footprint in its class ... a height of 30" (76.2 cm). Recognizing that space is ...
    Breaking Medicine Technology:Drug Patent Watch 2Drug Patent Watch 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2
    Cached News: